Pfizer Lilly: Different Bets on Pharma M&A Explained
Eli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
Find out what makes a good retirement strategy and how you can build wealth for a secure future. Implement these tips to enhance your retirement plan.
18,857 articlesEli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
As tariffs and a stronger dollar shape markets, IDV’s 4.7% yield just proved its income stream can endure, even as qu...
New market data shows most active managers fail to beat the S&P 500 over extended periods. This story explains the fo...
A hedge fund trend today centers on a lean, two-name portfolio. INDUS Capital Partners boosted its bet on H World Gro...
Grab is accelerating its push into physical AI and automated driving, testing robots in Singapore and at its own offi...
Two popular short-term corporate bond ETFs share many similarities, but subtle differences can matter for your portfo...
Poet Technologies has seen its stock retreat after a fast run-up. This guide breaks down why poet technologies stock ...
AI demand is reshaping semiconductors, putting Micron and Intel in the spotlight. This guide breaks down which could ...
China is rebooting after a sluggish 2023-24 period, yet the idea that the next china still remains central to worldwi...
Kick off your week with a clear view of the investing landscape. This Sunday Reads digest breaks down ten timely stor...
A Sunrun co-founder disclosed the sale of 50,000 shares, prompting questions about timing and implications. This arti...
A weekend scene at Stanford’s commencement drew sharp reaction from a renowned Silicon Valley investor after proteste...